Cancer Research AACR Conference on Molecular Diagnostics - 2008  AACR Conference on Molecular Diagnostics - 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 59, 3627-3633, August 1, 1999]
© 1999 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Thun-Battersby, S.
Right arrow Articles by Löscher, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Thun-Battersby, S.
Right arrow Articles by Löscher, W.
[Cancer Research 59, 3627-3633, August 1, 1999]
© 1999 American Association for Cancer Research


Carcinogenesis

Exposure of Sprague-Dawley Rats to a 50-Hertz, 100-µTesla Magnetic Field for 27 Weeks Facilitates Mammary Tumorigenesis in the 7,12-Dimethylbenz[a]-anthracene Model of Breast Cancer1

Susanne Thun-Battersby, Meike Mevissen2 and Wolfgang Löscher3

Department of Pharmacology, Toxicology and Pharmacy, School of Veterinary Medicine Hannover, D-30559 Hannover, Germany

We have shown previously (W. Löscher et al., Cancer Lett., 71: 75–81, 1993; M. Mevissen et al., Carcinogenesis (Lond.), 17: 903–910, 1996) that 50-Hz magnetic fields (MFs) of low [50 or 100 µTesla (T)] flux density enhance mammary gland tumor development and growth in the 7,12-dimethylbenz[a]anthracene (DMBA) model of breast cancer in female Sprague Dawley rats. In these previous experiments, groups of rats were given 20 mg of DMBA (four weekly gavage doses of 5 mg each) and were MF- or sham-exposed for 13 weeks. The objective of the present study was to examine whether the use of a lower dose of DMBA (10 instead of 20 mg per rat), MF exposure of the rats before DMBA injection, and the increase of the MF exposure period after DMBA application to 26 weeks enhance the effect of MF on tumor development and growth. A group 99 rats was exposed to a homogeneous, horizontally polarized 100-µT MF of 50-Hz for 24 h/day for 7 days/week; another group of 99 rats was sham-exposed under the same environmental conditions as the MF-exposed rats. The exposure chambers were identical for MF-exposed and sham-exposed animals. The age of the rats was 45–49 days at the onset of exposure; duration of MF or sham exposure was 27 weeks. DMBA was administered p.o. at a dose of 10 mg/rat after 1 week of MF or sham exposure. The animals were palpated once weekly from week 6 onwards to assess the development of mammary tumors. At the end of the exposure period, the animals were killed for the determination of number and volume and histological verification of mammary tumors. All of the recordings were done in a blinded fashion; i.e., the investigators were not aware which animals were MF- or sham-exposed. Mammary tumor development and growth was significantly enhanced by MF exposure, the most marked effect on tumor incidence (190% above sham control) being observed 13 weeks after DMBA administration. At the time of necropsy, i.e., 26 weeks after DMBA administration, the incidence of histologically verified mammary tumors was 50.5% in controls and 64.7% in MF-exposed rats, the difference being statistically significant. More marked intergroup differences were recorded when tumor incidence was separately evaluated for each of the six mammary complexes, the most pronounced MF effect on tumor incidence being seen in the cranial thoracic complex. The data substantiate that, at least under the experimental conditions used in our laboratory, 50-Hz, 100-µT MF exposure significantly facilitates the development and growth of mammary tumors in the DMBA rat model of breast cancer.




This article has been cited by other articles:


Home page
CarcinogenesisHome page
M. Fedrowitz and W. Loscher
Exposure of Fischer 344 rats to a weak power frequency magnetic field facilitates mammary tumorigenesis in the DMBA model of breast cancer
Carcinogenesis, January 1, 2008; 29(1): 186 - 193.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
T. C. Erren
RE: "OCCUPATIONAL MAGNETIC FIELDS AND FEMALE BREAST CANCER: A CASE-CONTROL STUDY USING SWEDISH POPULATION REGISTERS AND NEW EXPOSURE DATA"
Am. J. Epidemiol., August 15, 2005; 162(4): 392 - 393.
[Full Text] [PDF]


Home page
Cancer Res.Home page
M. Fedrowitz, K. Kamino, and W. Loscher
Significant Differences in the Effects of Magnetic Field Exposure on 7,12-Dimethylbenz(a)anthracene-Induced Mammary Carcinogenesis in Two Substrains of Sprague-Dawley Rats
Cancer Res., January 1, 2004; 64(1): 243 - 251.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
S. J. London, J. M. Pogoda, K. L. Hwang, B. Langholz, K. R. Monroe, L. N. Kolonel, W. T. Kaune, J. M. Peters, and B. E. Henderson
Residential Magnetic Field Exposure and Breast Cancer Risk: A Nested Case-Control Study from a Multiethnic Cohort in Los Angeles County, California
Am. J. Epidemiol., November 15, 2003; 158(10): 969 - 980.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. Fedrowitz, J. Westermann, and W. Loscher
Magnetic Field Exposure Increases Cell Proliferation but Does Not Affect Melatonin Levels in the Mammary Gland of Female Sprague Dawley Rats
Cancer Res., March 1, 2002; 62(5): 1356 - 1363.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1999 by the American Association for Cancer Research.